Your browser doesn't support javascript.
loading
Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage.
Barden, A E; Mas, E; Croft, K D; Phillips, M; Mori, T A.
Affiliation
  • Barden AE; School of Medicine & Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, WA 6000, Australia. Electronic address: anne.barden@uwa.edu.au.
  • Mas E; School of Medicine & Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, WA 6000, Australia.
  • Croft KD; School of Medicine & Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, WA 6000, Australia.
  • Phillips M; West Australian Institute for Medical Research, University of Western Australia, Perth, WA 6000, Australia.
  • Mori TA; School of Medicine & Pharmacology, Royal Perth Hospital, University of Western Australia, Perth, WA 6000, Australia.
Anal Biochem ; 449: 129-31, 2014 Mar 15.
Article de En | MEDLINE | ID: mdl-24380789
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: F2-isoprostanes Limites: Humans Langue: En Journal: Anal Biochem Année: 2014 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: F2-isoprostanes Limites: Humans Langue: En Journal: Anal Biochem Année: 2014 Type de document: Article Pays de publication: États-Unis d'Amérique